By Brendan Pierson and Dietrich Knauth
由布伦丹·皮尔森和迪特里希·克诺斯
July 26 (Reuters) - A Jury on Friday Found That Abbott Laboratories' Abt.n Specialized Formula for Premature Infants Caused an Illinois Girl to Develop a Dangerous Bowel Disease, Ordering the Healthcare Company to Pay $95 Million in Compensatory Damages.
7月26日(路透社)——周五陪审团认为，Abbott Laboratories公司的专门配方用于早产儿会导致伊利诺伊州的一个女孩患上危险的肠道疾病，并命令医疗保健公司支付9500万美元的赔偿金。Abt.n这一 verd(试判) 结果出现在密苏里州的圣路易斯州法庭上，是针对Abbott Laboratories 公司的第一起涉及该配方的数百项相似索赔之一，这些索赔在全国各地的法院中还在等待裁决。路透社通过法庭视听网络查看了这一过程。陪审团现在将考虑是否给这个女孩的母亲追加惩罚性赔偿金。
The Verdict in St. Louis, Missouri State Court Comes in the First Trial Against the Company Out of Hundreds of Similar Claims Over the Formula Pending in Courts Around the Country, Which Reuters Viewed via Courtroom View Network. the Jury Will Now Consider Whether to Award the Girl's Mother Punitive Damages.
(Reporting by Brendan Pierson and Dietrich Knauth in New York, Editing by Alexia Garamfalvi and Diane Craft)
（纽约的布伦丹·皮尔森（Brendan Pierson）和迪特里希·克诺斯（Dietrich Knauth）报道，亚历克西娅·加兰法尔维（Alexia Garamfalvi）和戴安娜·克拉夫特（Diane Craft）编辑）
((Brendan.pierson@Thomsonreuters.com; 332-219-1345 (Desk); 646-306-0235 (Cell);))
((Brendan.pierson@Thomsonreuters.com; 332-219-1345(办公室)；646-306-0235(手机)；）